Why the study?
With an aging population and expanding options for antiplatelet and anticoagulant regimens, broad knowledge is required to balance the efficacy of antithrombotic therapy in ischemic disease against the risk of bleeding complications and manage reversal.
This review summarizes current evidence on the proper selection, administration, and reversal of antithrombotic therapies to balance ischemic efficacy and bleeding risks.
May guide antithrombotic decisions in neurosurgery; leaves open need for prospective trials to validate protocols.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Suehiro et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: